Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ark postpones LSE (London Stock Exchange) float:

This article was originally published in Clinica

Executive Summary

Unusual market conditions" have prompted UK biotechnology company Ark Therapeutics to postpone its flotation on the London Stock Exchange. The London-based company, which develops medical products and pharmaceuticals aimed at vascular disease and cancer, had planned to raise up to $57 million in the offering (see Clinica No 1003, p 14). CEO Nigel Parker stressed that the company had been "extremely well received" at all investor meetings and that it intended to return to the capital markets when conditions were more favourable.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel